Physician profile
Abdullah Omar
NPI 1891059614
$14,535.46
in general payments reported to CMS, 2019-2025
29 companies · $1,506 in 2025
The $1,506 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $931 · 2020: $1,836 · 2021: $2,233 · 2022: $5,140 · 2023: $1,722 · 2024: $1,168 · 2025: $1,506.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,396.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,395.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $3,709.83 | 2021-2025 | Micra, Affera Mapping System, Endurant Iis |
| Boston Scientific Corporation | $3,093.30 | 2020-2025 | Farapulse, Fineline II Sterox, Watchman Flx |
| Abbott Laboratories | $1,835.61 | 2019-2025 | Ensite, Agilis Hispro, Amplatzer Amulet |
| Biotronik INC. | $1,827.73 | 2021-2022 | |
| Biosense Webster, INC. | $1,519.85 | 2021-2025 | Carto 3, Qdot Micro Catheter, Octaray Mapping Catheter |
| Medtronic Vascular, INC. | $760.35 | 2019 | |
| Atricure, INC. | $358.99 | 2023-2025 | Synergy Ablation System |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $331.90 | 2023-2025 | Lifevest |
| Cardiva Medical, INC. | $236.59 | 2023-2024 | Cardiva Vascade Mvp Vvcs 6-12f, Ensoetm |
| Novartis Pharmaceuticals Corporation | $146.91 | 2023-2025 | |
| Cordis US Corp. | $112.09 | 2024-2025 | Mynx Control Venous, Mynx Control, Mynx Venous Vcd |
| Intuitive Surgical, INC. | $71.65 | 2025 | |
| E.R. Squibb & Sons, L.L.C. | $69.75 | 2023-2025 | Camzyos |
| Cvrx, INC. | $67.85 | 2024-2025 | Barostim Neo System |
| Pfizer INC. | $63.92 | 2023-2025 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| W. L. Gore & Associates, INC. | $41.67 | 2019 | |
| Baxter Healthcare | $34.16 | 2025 | |
| Amgen INC. | $30.03 | 2025 | Repatha |
| Edwards Lifesciences Corporation | $27.19 | 2024 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Novo Nordisk INC | $24.45 | 2025 | Wegovy |
| Vektor Medical INC. | $24.03 | 2025 | Vmap |
| Merck Sharp & Dohme LLC | $23.77 | 2023 | Verquvo |
| Boehringer Ingelheim Pharmaceuticals, INC. | $21.71 | 2025 | Jardiance |
| Scpharmaceuticals INC. | $21.05 | 2025 | |
| Kiniksa Pharmaceuticals International, Plc | $20.89 | 2024 | Arcalyst |
| Bayer Healthcare Pharmaceuticals INC. | $18.85 | 2025 | |
| Bridgebio Pharma, INC. | $14.37 | 2025 | Attruby |
| Irhythm Technologies, INC. | $13.61 | 2024 | Zio Monitor, Zio Xt Patch |
| Alnylam Pharmaceuticals INC. | $13.36 | 2024 | Onpattro |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Abdullah Omar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.